Illinois General Assembly - Bill Status for HB5300
Illinois General Assembly

Previous General Assemblies

 Bill Status of HB5300  102nd General Assembly


Short Description:  INS-INSULIN DISCOUNT PROGRAMS

House Sponsors
Rep. Will Guzzardi - Kathleen Willis - Jonathan Carroll - Dagmara Avelar, Theresa Mah, Rita Mayfield, Kelly M. Cassidy, Anna Moeller, Katie Stuart, Debbie Meyers-Martin, William Davis, Barbara Hernandez, Deb Conroy, Daniel Didech, Sue Scherer, Terra Costa Howard, Michelle Mussman, Michael Halpin, Delia C. Ramirez, Anne Stava-Murray, Lindsey LaPointe, Janet Yang Rohr and Joyce Mason

Last Action
DateChamber Action
  1/10/2023HouseSession Sine Die

Statutes Amended In Order of Appearance
New Act
30 ILCS 105/5.970 new
215 ILCS 5/356z.41


Synopsis As Introduced
Creates the Insulin for All Act. Provides that the Department of Public Health shall offer a discount program that allows participants to purchase insulin at a discounted, post-rebate price. Sets forth provisions concerning an insulin urgent-need program. Provides that by July 1, 2022, each manufacturer shall establish procedures to make insulin available to eligible individuals who are in urgent need of insulin or who are in need of access to an affordable insulin supply. Sets forth provisions concerning insulin urgent-need program exceptions, eligibility, forms, applications, claims and reimbursement, copayments, information sheets, navigators, and penalties. Sets forth provisions concerning an insulin patient assistance program and manufacturer responsibilities and process of the patient assistance program. Sets forth provisions concerning dispute resolution, reports, and penalties for insulin programs. Creates the Insulin Assistance Fund. Defines terms. Amends the Illinois Insurance Code. In provisions concerning cost sharing in prescription insulin drugs, provides that an insurer that provides coverage for prescription insulin drugs under the terms of a health coverage plan the insurer offers shall limit the total amount that an insured is required to pay for a 30-day supply of covered prescription insulin drugs at an amount not to exceed $35 (rather than $100). Makes a conforming change in the State Finance Act. Makes other changes. Effective immediately.

Actions 
DateChamber Action
  1/28/2022HouseFiled with the Clerk by Rep. Will Guzzardi
  1/28/2022HouseAdded Co-Sponsor Rep. Theresa Mah
  1/28/2022HouseAdded Chief Co-Sponsor Rep. Kathleen Willis
  1/28/2022HouseAdded Co-Sponsor Rep. Rita Mayfield
  1/28/2022HouseAdded Co-Sponsor Rep. Kelly M. Cassidy
  1/28/2022HouseAdded Co-Sponsor Rep. Anna Moeller
  1/28/2022HouseAdded Co-Sponsor Rep. Katie Stuart
  1/28/2022HouseAdded Co-Sponsor Rep. Jonathan Carroll
  1/28/2022HouseAdded Co-Sponsor Rep. Debbie Meyers-Martin
  1/28/2022HouseAdded Co-Sponsor Rep. William Davis
  1/28/2022HouseAdded Co-Sponsor Rep. Barbara Hernandez
  1/28/2022HouseAdded Co-Sponsor Rep. Deb Conroy
  1/28/2022HouseAdded Co-Sponsor Rep. Daniel Didech
  1/28/2022HouseAdded Co-Sponsor Rep. Sue Scherer
  1/28/2022HouseRemoved Co-Sponsor Rep. Jonathan Carroll
  1/31/2022HouseFirst Reading
  1/31/2022HouseReferred to Rules Committee
  2/1/2022HouseAdded Chief Co-Sponsor Rep. Jonathan Carroll
  2/1/2022HouseAdded Co-Sponsor Rep. Terra Costa Howard
  2/1/2022HouseAdded Co-Sponsor Rep. Michelle Mussman
  2/1/2022HouseAdded Co-Sponsor Rep. Michael Halpin
  2/7/2022HouseAdded Chief Co-Sponsor Rep. Dagmara Avelar
  2/9/2022HouseAssigned to Executive Committee
  2/17/2022HouseAdded Co-Sponsor Rep. Delia C. Ramirez
  2/18/2022HouseRule 19(a) / Re-referred to Rules Committee
  2/22/2022HouseAdded Co-Sponsor Rep. Anne Stava-Murray
  2/22/2022HouseAdded Co-Sponsor Rep. Lindsey LaPointe
  2/24/2022HouseAdded Co-Sponsor Rep. Janet Yang Rohr
  3/1/2022HouseAdded Co-Sponsor Rep. Joyce Mason
  1/10/2023HouseSession Sine Die

Back To Top